Navigation Links
Cytochroma announces appointment of Ulrik Spork to Board of Directors
Date:10/30/2008

MARKHAM, ON, Oct. 30 /PRNewswire/ - Cytochroma today announced the appointment of Ulrik Spork to its Board of Directors. Mr. Spork will represent Novo A/S on the Company's Board and replaces Dr. Soren Schifter, who is leaving Novo A/S. The number of Board members remains unchanged at six members.

"We are very pleased to welcome Ulrik Spork to our board and look forward to drawing on his expertise and experiences as we continue building Cytochroma into a leading CKD-focused specialty pharmaceutical company," stated Alan Lewis, Ph.D., Chairman of Cytochroma's Board of Directors. "We would also like to thank Soren Schifter for his advice to Cytochroma over the years, and wish him well in the future."

Ulrik Spork has significant experience in corporate strategy, business development, M&A, product development, and international marketing. As Senior Partner, he led the establishment of venture investment activities by Novo A/S from its inception in 1999. Prior to the formation of Novo A/S, Mr. Spork was Director of Corporate Development at Novo Nordisk A/S, during which he was involved in that company's strategic planning and managed a number of acquisitions. He holds an MSc in Engineering from the Technical University of Copenhagen and a BSc in International Economics.

About Cytochroma

Cytochroma is a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism associated with chronic kidney disease (CKD). The Company's vitamin D-based therapeutics are designed to safely and effectively treat patients with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat hyperphosphatemia in these same patients. For more information, please visit http://www.cytochroma.com.


'/>"/>
SOURCE Cytochroma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cytochroma initiates Phase I/II clinical trial of CTAP101 Capsules for vitamin D insufficiency in chronic kidney disease
2. Cytochroma opens U.S. headquarters in Illinois
3. Cytochroma Appoints R. Richard Wieland II As CFO
4. Cytochroma Closes $45 Million Series C Financing
5. Cytochroma and Mitsubishi Tanabe form partnership for chronic kidney disease therapies in U.S. and Asia
6. Cytochroma appoints Steven I. Engel as Vice President of Regulatory Affairs and Quality Assurance
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 LC Sciences ... technologies, announced today that it is seeking beta ... innovative multiplex PCR based targeted sequencing technology. The ... analysis, that enables accurate detection of rare variants. ... Omega-Primer™ technologies. The company will collaborate with beta ...
(Date:4/16/2015)... (PRWEB) April 17, 2015 Spirax ... system services, released their newly designed, state-of-the-art website ... customer facing website effectively promotes the Spirax Sarco ... All the information that a site visitor might ... services, company capabilities, industries serviced, the latest company ...
(Date:4/16/2015)... Mass. (PRWEB) April 16, 2015 ... smart data solutions driven by Semantic Web technology, ... of specialist information and services for the academic ... announced that its joint solution ‘Smart Data Lake ... a finalist for the 2015 Bio-IT ‘Best of ...
(Date:4/16/2015)... April 16, 2015 Capillus, LLC ... and physician network in Europe and Asia. The ... appointed Fernando Bermúdez, former Business Development Director of ... industry veteran, Mr. Bermúdez’s professional achievements include increasing ... Spain, while also penetrating the Portuguese marketplace with ...
Breaking Biology Technology:LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Spirax Sarco website has a new look 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3Capillus, LLC Extends Laser Hair Therapy Products to Europe and Asia 2
... NOVEMBER 4, 2008, SAN DIEGO, Oct. 27 ... Kevin Gorman, President and Chief,Executive Officer of Neurocrine Biosciences ... in New York., The live presentation takes place ... /7:00 a.m. Pacific Time (PT). The presentation will,be simultaneously ...
... at 4:30 p.m. ET -, SOUTH SAN FRANCISCO, ... ) today reported financial results for the,quarter ended September ... million for the third quarter of,2008, 55% higher than ... was driven by revenue from Trofile(TM) for selecting HIV ...
... Lead Epidemiologist, RALEIGH, N.C., Oct. 27 ... the appointment of Dr.,Jerome Wilson as Senior Medical ... Dr. Wilson is responsible for providing consulting,services and ... provides extensive Phase IV Post-Marketing services to,pharmaceutical and ...
Cached Biology Technology:Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference 2Monogram Announces 2008 Third Quarter Financial Results 2Monogram Announces 2008 Third Quarter Financial Results 3Monogram Announces 2008 Third Quarter Financial Results 4Monogram Announces 2008 Third Quarter Financial Results 5Monogram Announces 2008 Third Quarter Financial Results 6Monogram Announces 2008 Third Quarter Financial Results 7Monogram Announces 2008 Third Quarter Financial Results 8Monogram Announces 2008 Third Quarter Financial Results 9Monogram Announces 2008 Third Quarter Financial Results 10Monogram Announces 2008 Third Quarter Financial Results 11Monogram Announces 2008 Third Quarter Financial Results 12Monogram Announces 2008 Third Quarter Financial Results 13Monogram Announces 2008 Third Quarter Financial Results 14Monogram Announces 2008 Third Quarter Financial Results 15Jerome Wilson Joins PRA International's Late Phase Service Group 2
(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has ... Strategic Business Report" report to their offering. ... US$ Thousands. The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... Latin America . Annual estimates and forecasts ...
(Date:3/17/2015)... 17, 2015 MedNet Solutions , ... clinical study management systems, is pleased to announce ... ARENA,s Outsourcing in Clinical Trials Southeast conference – ... an excellent forum for MedNet to showcase ... software-as-a-service (SaaS) eClinical technology platform. We ...
(Date:3/16/2015)... March 16, 2015 Between ... will present groundbreaking innovations in biometric identification at ... .      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ... innovation is well at the forefront: the company,s ... made in Germany . BiometricGate ...
Breaking Biology News(10 mins):Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3
... in Denmark revealed that increasing levels of non-fasting triglycerides ... in men and women. Higher cholesterol levels were associated ... this novel, 33-year study are now available online in ... Wiley-Blackwell on behalf of the American Neurological Association. ...
... decoded the DNA of the parasitic worm that causes ... pork or carnivorous wild game animals, such as bear ... Washington University School of Medicine in St. Louis and ... the parasite, Trichinella spiralis , which provide potential ...
... to different climates and diets as they split off from other ... for humans living today? A panel of scholars from ... Sunday February 20th at the AAAS meeting in Washington, DC, as ... at Work In Humans and Their Relatives." The speakers ...
Cached Biology News:Increasing triglyceride levels linked to greater stroke risk 2Trichinosis parasite gets DNA decoded 2Panelists to discuss evolution of human brain size, skin color and diet at AAAS meeting 2
... the most comprehensive, cost-effective solution to ... incorporated unprecedented quality into both our ... proven detection chemistries and antibodies that ... protocol. It also includes our competitively ...
... Signet Level 2 Detection System combines ... chemical bonding principle and Signets unique ... sensitivity, specificity and reliablility. Signet reagents ... both manual and automated protocols. ,Signets ...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets USA ...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets ...
Biology Products: